{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:29:09Z","timestamp":1794608949629,"version":"4.9.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vascn.2025.108378","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T11:59:15Z","timestamp":1750679955000},"page":"108378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Toxicology and safety pharmacology investigations on the nervous system: 2024 industry survey"],"prefix":"10.1016","volume":"135","author":[{"given":"Simon","family":"Authier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus S.","family":"Delatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Wakeford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"McMaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa B.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Traebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Sokolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Pugsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2025.108378_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vascn.2016.06.001","article-title":"Safety pharmacology investigations on the nervous system: An industry survey","volume":"81","author":"Authier","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108378_bb0010","author":"Chen"},{"key":"10.1016\/j.vascn.2025.108378_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tiv.2018.12.001","article-title":"Assessing seizure liability using multi-electrode arrays (MEA)","volume":"55","author":"Fan","year":"2019","journal-title":"Toxicology In Vitro"},{"issue":"1","key":"10.1016\/j.vascn.2025.108378_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13578-024-01258-w","article-title":"Chemical screen in zebrafish lateral line identified compounds that ameliorate neomycin-induced ototoxicity by inhibiting ferroptosis pathway","volume":"14","author":"Fan","year":"2024","journal-title":"Cell & Bioscience"},{"issue":"2","key":"10.1016\/j.vascn.2025.108378_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1091581818824313","article-title":"CDER experience with juvenile animal studies for CNS drugs","volume":"38","author":"Fisher","year":"2019","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2025.108378_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105116","article-title":"De-risking in tier I CNS safety assessments is the primary function of study design and technical training of laboratory staff observers","volume":"129","author":"Gauvin","year":"2022","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2025.108378_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cotox.2017.08.002","article-title":"Immunotoxicology: A brief history, current status and strategies for future immunotoxicity assessment","volume":"5","author":"Germolec","year":"2017","journal-title":"Current Opinion in Toxicology"},{"issue":"4","key":"10.1016\/j.vascn.2025.108378_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1091581817699975","article-title":"Points to consider in designing and conducting juvenile toxicology studies","volume":"36","author":"Kim","year":"2017","journal-title":"International Journal of Toxicology"},{"issue":"5","key":"10.1016\/j.vascn.2025.108378_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103966","article-title":"2023 in review: FDA approvals of new medicines","volume":"29","author":"Kinch","year":"2024","journal-title":"Drug Discovery Today"},{"issue":"6","key":"10.1016\/j.vascn.2025.108378_bb0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1091581819883569","article-title":"Evaluation of juvenile animal studies for pediatric CNS-targeted compounds: A regulatory perspective","volume":"38","author":"van der Laan","year":"2019","journal-title":"International Journal of Toxicology"},{"issue":"14","key":"10.1016\/j.vascn.2025.108378_bb0065","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2174\/1871530323666230413081128","article-title":"New approach methodologies in immunotoxicology: Challenges and opportunities","volume":"23","author":"Maddalon","year":"2023","journal-title":"Endocrine, Metabolic & Immune Disorders Drug Targets"},{"key":"10.1016\/j.vascn.2025.108378_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.psychres.2019.07.004","article-title":"A systematic review of quantitative EEG as a possible biomarker in child psychiatric disorders","volume":"279","author":"McVoy","year":"2019","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.vascn.2025.108378_bb0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.yrtph.2016.05.002","article-title":"Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials","volume":"80","author":"Mead","year":"2016","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2025.108378_bb0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10198-023-01639-x","article-title":"Special FDA designations for drug development: Orphan, fast track, accelerated approval, priority review, and breakthrough therapy","volume":"25","author":"Michaeli","year":"2024","journal-title":"The European Journal of Health Economics"},{"issue":"4","key":"10.1016\/j.vascn.2025.108378_bb0085","first-page":"226","article-title":"$1.3 billion per drug?","volume":"19","author":"Mullard","year":"2020","journal-title":"Nature Reviews Drug Discovery"},{"issue":"2","key":"10.1016\/j.vascn.2025.108378_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/d41573-025-00001-5","article-title":"2024 FDA Approvals","volume":"24","author":"Mullard","year":"2025","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.vascn.2025.108378_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105029","article-title":"Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice","volume":"126","author":"Namdari","year":"2021","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2025.108378_bb0100","doi-asserted-by":"crossref","first-page":"1379743","DOI":"10.3389\/fnmol.2024.1379743","article-title":"Ototoxicity: A high risk to auditory function that needs to be monitored in drug development","volume":"17","author":"Pasdelou","year":"2024","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"427","key":"10.1016\/j.vascn.2025.108378_bb0105","article-title":"Effects of new antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish","volume":"15","author":"Pier\u00f3g","year":"2021","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.vascn.2025.108378_bb0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.stem.2024.01.007","article-title":"Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes","volume":"7;31(3)","author":"Raniga","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.vascn.2025.108378_bb0115","series-title":"The principles of humane experimental technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.vascn.2025.108378_bb0120","doi-asserted-by":"crossref","first-page":"1055424","DOI":"10.3389\/fphar.2022.1055424","article-title":"Zebrafish EEG predicts the efficacy of antiepileptic drugs","volume":"13","author":"Shin","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.vascn.2025.108378_bb0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.vascn.2008.01.004","article-title":"Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs","volume":"57","author":"Winter","year":"2008","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.108378_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107297","article-title":"Comparative study for the IMI2-NeuroDeRisk project on microelectrode arrays to derisk drug-induced seizure liability","volume":"123","author":"Zhai","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871925007981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871925007981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:18:42Z","timestamp":1760213922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871925007981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"alternative-id":["S1056871925007981"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2025.108378","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicology and safety pharmacology investigations on the nervous system: 2024 industry survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2025.108378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108378"}}